[Hormone therapy and urogynecology]

Area of Science:

• Urogynecology
• Endocrinology

Context:

• The female genital and urinary systems are anatomically and functionally interconnected.
• Dysfunction in one system often impacts the other, necessitating a holistic approach to diagnosis and management.
• Lower urinary tract disorders require consideration of this relationship, as they cannot be viewed in isolation.

Purpose:

• To evaluate the role and efficacy of estrogen replacement therapy (ERT) in managing female lower urinary tract disorders.
• To explore the benefits of ERT beyond urinary incontinence, including recurrent urinary tract infections (UTIs) and atrophic vaginitis.
• To assess the overall therapeutic value of hormone replacement therapy (HRT) in urogynecological conditions.

Summary:

• Evidence for estrogen therapy alone in treating urinary incontinence, particularly stress urinary incontinence, remains controversial and limited.
• Systemic ERT demonstrates effectiveness in alleviating symptoms like urgency, urge incontinence, frequency, nocturia, and dysuria.
• Topical low-dose estrogen is effective for managing atrophic vaginitis, and ERT can prevent or treat recurrent UTIs.

Impact:

• While ERT's direct impact on urinary incontinence is debated, its benefits for UTIs and genitourinary symptoms are significant.
• ERT may serve as an adjunctive therapy, supporting other causal treatments for lower urinary tract dysfunction in postmenopausal women.
• Understanding the multifaceted benefits of ERT is crucial for comprehensive urogynecological care.